Member Info for ryn82

Welcome mate and good luck. Looking for 0.4p minimum imo. Value of assets here way higher than current market cap, largely ignored by the market. Horse hill has had no value ascribed here, maybe the market has missed it so far

At all that, mar cap only £1.5m!

Is extremely undervalued Around £700k cash Bodo £700k cost VENN £250k plus royalties ALBA 55m shares = £400k+ BMG shares £60k HHDL cost £425k before the news as moreforus says, EVO holding in HH could be worth around 4p alone. This should by pushing on as the likes of UKOG and ALBA have. Gla

Agreed! The money was supposed to help increase production at the Bodo mine from 50 to 150-200 tonnes per day. At say $250 per tonne that's a top line $1.5m per month. They also say there are other open pit areas suitable for similar production and that is what the money from the additional option is. If the one open pit is hitting $1.5m revenue now that's $17m revenue per year - obviously only 10% of it is to EVO at the moment but look at the market cap! Then there's cash £650k VENN holding £250k plus royalties of 7.5% and 25% HHDL which cost £425k before the HH news 55m ALBa shares worth around £300k And nominal amount in NMG £60k Updates are required! Also look at VENN outlook - pipeline of $18m sales for 2015 alone!

you got a link to the video pls?

in the RNS, if you read further down "For the avoidance of doubt, any such further investment would be on the basis that such holding remained significantly below 50% and on the basis that the Company remains classified as an Investing Company under the AIM Rules for Companies." so we are at 46% odd, they are reducing significantly, to me maybe 20-25% holding? so with 512m shares including warrants this gives them imo around 250m shares to sell, now we know they have sold 50m for £1.3m, if they can achieve roughly the same price thats an additional £6.5m. That goes ontop of the £3.5m sold thus far giving us £10m in cash, and still 25% of PUCF valued at around £6.5m. We are capped at £5m! of course they may sell agressively and even to say 10% holding which may affect the £ generated. What RHM have shown is that they CAN sell their shares on the market, and they sold the last 50m within a few weeks. They may also arrange for a stock transfer to a willing buyer off book. GLA!

Is undervalued. £650k cash £700k Investment in Bodo to increase operations at mine £250k in VENN £61k in NMG £340k in ALBA £425k spent on Horsehill £2.43m Plus there's the VENN royalties of 8.5% and 25% to come. It's interesting that UKOG mar cap is £50 and have 21% of Horse-hill. EVO have 1.8% interest in horse hill via ALBA and investment in HHDL. Using UKOG as a benchmark as they are the largest holder of Horsehill that are listed on AIM then EVO holding could be worth as much as £4.3m. Then there is the other investments and cash on top. EVO capped at £1.8m looks pretty dam cheap.

so thats revenue of $450k per month or $5.4m. also "For the mill, funds will be utilised to modify the plant, which is expected to improve tungsten recoveries from approximately 65% to an anticipated recoveries of over 80%, by adding grinding equipment to fully liberate the tungsten mineral." so thats a 25% improvement in recovery, so that becomes $562k per months or $6.75m annually. Interestingly they think that 200 tonnes per day can be achieved ansd at recovery rates improved by 20% so could be as much as $450k / 50 current output * 200 potential output * 1.25 improvement in recovery = $2.25m per month or $27m annually. EVO have 10% of this for £700k, if the $27m per year is achieved this is $2.7m to EVO (£1.8m) So current 'base' value is £2.4m and potential of upto £7.8m, but even then royalties bieng royalties come each year. Current market cap of £1.6m is quite simply staggering.

£650k cash £425k HHDL cost £700k Bodo cost £250k Venn holding £?? Venn Royalties £60k NMG holding £337k ALBA holding £2.4m total Now, is Bodo or HHDL worth more than what it cost? UKOG = 21% interest in HH and £50m mar cap. EVO, taking into account direct HHDL investment and ALBA holding = 1.7%. UKOG valued at £2.38m per 1% of HH. Therefore EVO = £2.38m x 1.7 = £4m so revised £650k cash £4m HH investment (based on HHDL and ALBA holding using UKOG value as benchmark) £250k Venn holding £?? Venn Royalties £60k NMG holding £5m total Now - what about the VENN royalties? looking over the last few VENN RNS's they have a $18m sales figure for the current year. 23 Dec 14 "the Company already has contracted revenue for next year in excess of €6m, as well outstanding proposals for new contracts worth a total of €18m" and since then 30 Mar 15 "Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces today the signing of new contracts worth over €4.1m with a leading US based Biotechnology client" and 2 Apr 2015 "Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that InnoVenn, the skin science division of Venn, has extended its product line and seen first sales in the US" I dont know the split between labskin (7.5% royalty) and SYN1113 (25% royalty) but if we took the lower case 7.5% of the $18m = $1.35m or £1m. Then there is Bodo - "The Bodó mine is currently operating at approximately 50-60 tonnes of ore per day from the Pajeù incline Shaft on a 6 day per week operation. The last shipment of tungsten concentrate from Bodó was on the 5th January 2015 with estimated gross proceeds from this shipment of $150,000. At an APT Price of $290/mtu, this translates into a gross sale value per tonne of standard export concentrate containing 68% WO3 of approximately $15,000/tonne" "Bodó is a high-grade tungsten operation employing 96 people, and is currently operating at the rate of about 50-60 tonnes of ore production per day from underground operations. The ore is being processed through an onsite treatment plant with a current capacity of about 200 tonnes per day. Tungsten concentrates are sold to the global export market under an existing sales agency agreement with Wogen Pacific Limited." So at 50-60 tonnes per day making $150k a month. and "It is intended that the funds provided by Evocutis will be specifically used to provide the necessary working capital to expand and improve the existing oper

well iCrazy Horse cost CDC $5m, its worth $500k now lol!

had two assets Bassay - Relinquished CDC holding in the Basay Project has remained fully impaired since 2012, after CDC completed an internal interim report for Basay project which provided a non-AIM compliant estimate of resource and grade that the Board has concluded was insufficient to support a mining operation, and also in view of the lack of progress on the renewal of the exploration permit, which expired in December 2012. Hinoba - asset held at $18m (its cost them $33m!) It is currently the intention of the Directors to realize its investment in the Hinoba-an project through a disposal Also £500k Cash £500k loan to MFX $500k USD holding in Crazy Horse

That court win removes a claim of $9.8m against them and IPSA get costs back. This has been rumbling on since nov 13 so costs could be sizeable to be recovered. RUR cash news also due and with recent SA government contract this is undervalued by somewhat.

put it this way, RHM will have green light to sell £7m worth of stock, add that to £3m cash already so £10m cash, maybe £8m allowing for discount, then will still have £8m in PUFC stock. Only £5m mar cap. Difference between now and last time RHM monitising the asset, hard cash. HARD CASH. They have sold as many as they can from an AIM perspective, down to 51%, shareholders need to agree to go below 50% and change AIM status/investment policy. Once accepted they can (and will as they have sold as much as they can so far) sell another £7m in stock.

RHI, holds, as at the date of this announcement, 543,168,402 ordinary shares in PUCF and From 1 January 2015 RHM is able to reduce its holding to 289,726,716 PUCF Shares so can sell half of £15m = £7m, add to cash of £3m RHM going to be cash rich to the tune of £10m, plus £8m held in PUFC. Look at the market cap!

check this out RHI, holds, as at the date of this announcement, 543,168,402 ordinary shares in PUCF and From 1 January 2015 RHM is able to reduce its holding to 289,726,716 PUCF Shares so can sell half of £15m = £7m, add to cash of £3m RHM going to be cash rich to the tune of £10m, plus £8m held in PUFC. Look at the market cap!

That RHM are basically asking shareholders if they can sell the PUCF stake, they have sold down to 51% and want to sell the rest but shareholders have to give the nod. Can we please sell our £15m stock in PUFC please as AIM not accounting for this value in the mar cap of £5m plus cash of £3m, shareholders are going to say yes!

need to behave here and close the spread

RHM per listing needed to keep over 50% holding PUC, holding less than 50% PUC changes their status and listing. To go under 50% needs a shareholder vote - hence RNS. Shows their intention to sell down PUC and realise that £15m in PUC. Dont forget alrady got £3m in cash, add that £15m holding in PUC they are going to sell, then look at mar cap now.

I have emailed the company to find out, also about VENN royalites

sells seem to have dried up and recent seller gone. Now, these VENN royalties???? 3.06% Stake in Venn Life Science, a royalty of 7.5% on the gross sales of LabSkin™ for 3 years from date of acquisition, and a royalty of 25% on the future sale of or out-licence agreements for SYN1113 looking at VENN, this is in an RNS regarding 2014:- This strong close has been driven by substantial contract wins since May this year exceeding €8m in total value and provides a firm foundation for 2015. The Company already has contracted revenue for next year in excess of €6m, as well outstanding proposals for new contracts worth a total of €18m. Also recently a new contract for $4.1m. so, in 2014 sales = $8m, so do EVo get $600k = £430k? If so when / how is this distributed to EVO? Theres no mention of VENN in the interims in April by EVO>